SCHEMBL4064265

SCHEMBL4064265

Cc1cc(OC(=O)O)cc2oc(=O)n(C)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.40
KDM4E B2RXH2 11/20 0.40
GAA P10253 10/20 0.40
ALDH1A1 P00352 9/20 0.40
GLA P06280 9/20 0.40
MAPT P10636 6/20 0.39
HPGD P15428 6/20 0.39
HSD17B10 Q99714 5/20 0.39
CASP1 P29466 4/20 0.39
CASP7 P55210 4/20 0.39
TSHR P16473 1/20 0.39
KMT2A Q03164 4/20 0.36
NPBWR1 P48145 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
HSP90AA1 P07900 1/20 0.35
HSP90AB1 P08238 1/20 0.35
ALPG P10696 1/20 0.35
ALOX15 P16050 1/20 0.35
ALOX12 P18054 1/20 0.35
CA12 O43570 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4073632 0.80 KMT2A (0.43) ACACBKDM4EALDH1A1HSD17B10KMT2A
SCHEMBL4064262 0.77 ALDH1A1 (0.44) ACACBKDM4EALDH1A1HPGDHSD17B10
SCHEMBL16435008 0.75 ACACB (0.43) ACACBKDM4EGAAALDH1A1GLA
SCHEMBL1286093 0.74 KDR (0.44) ACACBKDM4EGAAALDH1A1GLA
SCHEMBL12787337 0.74 ACACB (0.41) ACACBKDM4EALDH1A1HPGDTSHR
SCHEMBL3352484 0.71 ACACB (0.43) ACACBKDM4EALDH1A1HPGDKMT2A
SCHEMBL1285654 0.71 ACACB (0.39) ACACBKDM4EALDH1A1HPGDTSHR
SCHEMBL10187968 0.71 ACACB (0.39) ACACBKDM4EALDH1A1HPGDTSHR
SCHEMBL1285780 0.71 ALDH1A1 (0.41) ACACBKDM4EGAAALDH1A1GLA
SCHEMBL29951002 0.71 ACACB (0.40) ACACBKDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009034029-A2 1-SUBSTITUTED 4-HETEROCYCLYLPIPERIDINES FOR USE AS CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-19 WO disclosed